SurgePays, Inc. (SURG)
| Market Cap | 3.65M-94.7% |
| Revenue (ttm) | 67.06M |
| Net Income | -32.11M |
| EPS | -1.52 |
| Shares Out | 52.91M |
| PE Ratio | n/a |
| Forward PE | 14.52 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 725,379 |
| Open | 0.15 |
| Previous Close | 0.15 |
| Day's Range | 0.14 - 0.15 |
| 52-Week Range | 0.13 - 3.14 |
| Beta | 0.28 |
| Analysts | Buy |
| Price Target | 10.00(+6787.05%) |
| Earnings Date | Nov 11, 2026 |
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$SURG stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in SURG holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SURG's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SURG Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New SURG patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SURG from public contracts
Source: USAspending.gov
SURG Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from SURG’s recent data — informational, not investment advice